Thomas J. Cramer

Vascular remodeling underlies rebleeding in hemophilic arthropathy

Vikas Bhat, Merissa Olmer, Shweta Joshi et al. · American Journal of Hematology · 2015 · 96 citations · Full text

Vasculitis, Immunology, Pathology +24

Detailed Mechanisms of the Inactivation of Factor VIIIa by Activated Protein C in the Presence of Its Cofactors, Protein S and Factor V

Andrew J. Gale, Thomas J. Cramer, Diana Rozenshteyn et al. · Journal of Biological Chemistry · 2008 · 59 citations · Full text

Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant

Annette von Drygalski, Thomas J. Cramer, Vikas Bhat et al. · Journal of Thrombosis and Haemostasis · 2013 · 30 citations · Full text

Inflammation, Hemophilia Mice, Pathogenesis +8

Factor V Is an Anticoagulant Cofactor for Activated Protein C during Inactivation of Factor Va

Thomas J. Cramer, John H. Griffin, Andrew J. Gale · Pathophysiology of Haemostasis and Thrombosis · 2010 · 29 citations · Full text

The Hypertension of Hemophilia Is Not Explained by the Usual Cardiovascular Risk Factors: Results of a Cohort Study

R. F. W. Barnes, Thomas J. Cramer, Afrah S. Sait et al. · International Journal of Hypertension · 2016 · 28 citations · Full text